However, the most common measure of the systemic inflammatory response in cancer patients is the serum concentration of C‐reactive protein (CRP), which can identify patients who will likely develop cachexia and have a poor survival and response to treatment after combining with albumin to a scale 9, 15. This evidence concerns the gene CRP and cancer.